These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 750907)

  • 1. Naloxone in the treatment of schizophrenia.
    Wen HL; Lo CW; Ho WK; Mehal ZD; Ng YH; Lam S; Ma L
    Mod Med Asia; 1978 Dec; 14(12):51-5. PubMed ID: 750907
    [No Abstract]   [Full Text] [Related]  

  • 2. [Administration of naloxone in schizophrenic psychoses and manic syndromes].
    Verhoeven WM; van Praag HM; de Jong JT
    Ned Tijdschr Geneeskd; 1981 Apr; 125(14):532-7. PubMed ID: 6112715
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of the morphine antagonist naloxone in psychic disorders.
    Schenk GK; Enders P; Engelmeier MP; Ewert T; Herdemerten S; Köhler KH; Lodemann E; Matz D; Pach J
    Arzneimittelforschung; 1978; 28(8):1274-7. PubMed ID: 380575
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebrospinal fluid [Met5]enkephalin level in schizophrenics during treatment with naloxone.
    Lo CW; Wen HL; Ho WK
    Eur J Pharmacol; 1983 Aug; 92(1-2):77-81. PubMed ID: 6138259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Various aspects of the interaction between the dopamine and opiate systems in schizophrenia].
    Anokhina IP
    Vestn Akad Med Nauk SSSR; 1982; (1):37-40. PubMed ID: 7064531
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioral and neuroendocrine effects of opioid receptor agonists in psychopathologic states.
    Judd LL; Risch SC; Segal DS; Janowsky DS; Huey LY
    Psychiatr Clin North Am; 1983 Sep; 6(3):393-402. PubMed ID: 6359090
    [No Abstract]   [Full Text] [Related]  

  • 7. Naloxone in schizophrenia: negative result.
    Lipinski J; Meyer R; Kornetsky C; Cohen BM
    Lancet; 1979 Jun; 1(8129):1292-3. PubMed ID: 87747
    [No Abstract]   [Full Text] [Related]  

  • 8. Naloxone in chronic schizophrenia.
    Volavka J; Mallya A; Baig S; Perez-Cruet J
    Science; 1977 Jun; 196(4295):1227-8. PubMed ID: 860138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of beta-endorphin under chronic neuroleptic treatment in schizophrenic patients: failure of naloxone to counteract curative effects of neuroleptic drugs.
    Emrich HM; Höllt V; Bergmann M; Kissling W; Schmid W; Zerssen DV; Herz A
    Adv Biochem Psychopharmacol; 1980; 22():489-502. PubMed ID: 6104902
    [No Abstract]   [Full Text] [Related]  

  • 10. Repeated naloxone administration in schizophrenia.
    Verhoeven WM; van Praag HM; van Ree JM
    Psychiatry Res; 1984 Aug; 12(4):297-312. PubMed ID: 6594713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid agonists and antagonists in schizophrenia.
    Barchas JD; Berger PA; Watson SJ; Akil H; Li CH
    Adv Biochem Psychopharmacol; 1980; 22():447-53. PubMed ID: 7395601
    [No Abstract]   [Full Text] [Related]  

  • 12. [Opioid peptides as ligands of neuronal receptors].
    Vartanian ME; Lideman RR; Burbaeva GSh; Zozulia AA; Tsutsul'kovskaia MIa
    Vopr Med Khim; 1984; 30(3):73-9. PubMed ID: 6089431
    [No Abstract]   [Full Text] [Related]  

  • 13. [Endogenous opioids and gamma type endorphins in schizophrenia].
    Verhoeven WM
    Arch Neurobiol (Madr); 1983; 46(5):335-8. PubMed ID: 6362599
    [No Abstract]   [Full Text] [Related]  

  • 14. Naloxone in schizophrenia.
    Skrabanek P
    Lancet; 1982 Dec; 2(8310):1270. PubMed ID: 6128561
    [No Abstract]   [Full Text] [Related]  

  • 15. Naloxone in schizophrenia.
    Pickar D
    Lancet; 1983 Apr; 1(8328):819. PubMed ID: 6132151
    [No Abstract]   [Full Text] [Related]  

  • 16. Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects.
    Dalal MA; Schuld A; Pollmächer T
    Mol Psychiatry; 2003 Oct; 8(10):836-7. PubMed ID: 14515133
    [No Abstract]   [Full Text] [Related]  

  • 17. Multicenter trial of naloxone in Alzheimer's disease.
    Henderson VW; Roberts E; Wimer C; Bardolph EL; Chui HC; Damasio AR; Eslinger PJ; Folstein MF; Schneider LS; Teng EL
    Ann Neurol; 1989 Apr; 25(4):404-6. PubMed ID: 2653175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endomorphines in schizophrenia].
    Gilbert JL
    Biomed Pharmacother; 1987; 41(1):36-40. PubMed ID: 3038207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychopharmacology and endorphins].
    Langwiński R
    Psychiatr Pol; 1979; 13(6):533-42. PubMed ID: 531127
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased polydipsia in schizophrenic patients treated with naloxone.
    Nishikawa T; Tsuda A; Tanaka M; Nishikawa M; Koga I; Uchida Y
    Am J Psychiatry; 1994 Jun; 151(6):947. PubMed ID: 8185016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.